Aims: Ventricular arrhythmia is one of the most important causes of death in industrial countries and often accompanies myocardial infarction and heart failure. In recent years modification of gap-junctional coupling has been proposed as a new antiarrhythmic principle.
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Introduction:
Gap junction channels form the basis of intercellular communication in many organs. They allow propagation of action potentials (electrical coupling) as well as transfer of small molecules (metabolic coupling). In the cardiovascular system they play an important role in excitation spread in heart and maintaining a normal heart rhythm. Gap junction channels are formed by two hemichannels (connexons) each composed of 6 proteins called connexins.
There are several connexin isoforms known, from which the most important ones in heart are Cx43 which is the predominant isoform in working myocardium, Cx40 which is mainly found in conduction system and atrium and Cx45 which plays a role during development and is found in adult hearts in conduction system and at the border between myocytes and fibroblasts (for review see 1 ) .
Arrhythmia is one of the most important final causes of death in industrial countries and often accompanies myocardial infarction and heart failure. Gap junctional uncoupling has been identified as an important (among others) contributing factor in the pathophysiology of reentrant arrhythmia 2, 3 . In particular, during cardiac ischemia gap junction uncoupling occurs after about 15 minutes and has been linked to the initiation of ventricular fibrillation (type IB, typically after 20-40 minutes of ischemia).
In recent years a new antiarrhythmic principle has been proposed by modulation of gap junctional coupling by the use of antiarrhythmic peptides and their derivatives [4] [5] [6] [7] . The lead compound AAP10 (H 2 N-Gly-Ala-Gly-4Hyp-Pro-Tyr-CONH 2 ) was shown to enhance electrical coupling in rat and guinea pig cardiomyocytes 6, 8 , and to prevent from ischemia-induced type IB ventricular fibrillation 9 . Although these results could be reproduced by others and also with compounds chemically closely related to AAP10 7,10-14 , there are, however, still several important open questions:
by guest on Downloaded from Accepted Manuscript to +120mV for 2000ms in order to assess the voltage-dependent inactivation. Data in the latter case were fitted to the two-state Boltzmann equation 19 .
To determine the time course of gap junctional conductance a transjunctional voltage difference of -10mV for 200ms was applied once a minute. Before wash in of AAP10 (50nmol/l for 30min) 0.05% BSA was added to extracellular solution to block unspecific binding sites in the perfusion system. To determine the effect of AAP10 pre-treatment in gap junction uncoupling bicarbonate buffered Tyrode's solution (in mmol/l: NaCl 137, KCl 5, CaCl 2 2, MgCl 2 1, BaCl 2 1, NaHCO 3 24, NaH 2 PO 4 0.4, glucose 10) was used and has been adjusted to pH 6.3 by insufflations of 100% CO 2 . Based on the concentration-response curves of earlier studies 4,5,9 we have chosen 50 nM AAP10 as a test concentration, since in all test systems the antiarrhythmic peptides and AAP10 were effective in concentrations of 1-100 nM.
In additional experiments on human cardiomyocytes we treated uncoupling with AAP10 using the following protocol (AAP10 post-treatment): cell pairs were patched as described above and submitted to acidosis-induced uncoupling. After establishing uncoupling (10 min uncoupling) acidosis was continued and the cell pairs were additionally treated for 30 min with 50 nM AAP10.
Dye coupling:
In cultured neonatal rat cardiomyocytes and transfected HeLa cells permeability was determined by diffusion of the fluorescent dye Lucifer yellow (LY, MW 457.2) as described 20 .
There was microinjection of 0.1% LY in one cell and the number of coupled cells was determined after 1min dye transfer in cardiomyocytes and after 5min in HeLa cells, respectively. In HeLa Cx45 cells dye transfer was assessed by scrape load experiments using the gap junction permeable dye Lucifer yellow (LY, 0,05%) and the much larger gap junction impermeable dye rhodamine dextran (RD, MW 10000, 0.05%) [21] [22] . The cells were incubated for 30min with AAP10 (50 nmol/l) before scrape load. For analysis we determined by guest on May 1, 2016
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I(Na) measurement
Voltage clamp experiments were performed on isolated human cardiomyocytes following classical protocols 23 at a holding potential of -80 mV, which were clamped to -80 to +35 mV (pulse duration: 100 ms) (solutions: see above). The measured current was related to the cell capacity and expressed as [pA/pF].
Biochemistry
For biochemical analysis we used well established procedures for immunocytochemistry and western blot analysis using the following antibodies: rabbit-anti-Cx40 (AB1726, Chemicon), rabbit-anti-Cx43 (C6219, Sigma-Aldrich, Munich, Germany), mouse-anti-Cx45 (MAB3100, Chemicon) and FITC-conjugated secondary antibodies: swine-anti-rabbit (F0205, DAKO, Hamburg, Germany) and rabbit-anti-mouse (F0261, DAKO). For further details see online data supplement.
Material:
AAP10 (H 2 N-Gly-Ala-Gly-4Hyp-Pro-Tyr-CONH 2 ) was gained by our own synthesis, HPLCpurified, purity >99%, as described previously 5, 9 .
Statistics:
We performed a multivariate analysis of variance using species; pH and treatment as factors, followed by an ad-hoc statistic test (t-test, with Bonferroni correction, if necessary). 
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The effect of AAP10 on gap junctional electrical coupling is enhanced in partially uncoupled cells Comparing the quantitative effects of AAP10 in partially uncoupled cells (pH 6.3) and in normal cells (pH 7.4) revealed that the AAP10 effect was significant under both conditions (p<0.01), and was significantly enhanced in the uncoupled cells at pH 6.3 (p=0.011) ( fig. 3A ).
The observed increase in Δj/Δt was significantly higher in uncoupled cells (p=0.011).
Regarding both species, AAP10 effects were comparable although somewhat (n.s., p=0.054) more pronounced in human cardiomyocytes.
Post-treatment with AAP10 reverses acidosis-induced uncoupling
If human cardiomyocytes were uncoupled and thereafter treated with AAP10, AAP10 also was effective in reversing acidosis-induced uncoupling: acidosis (pH 6.3) led to a decrease in Δj/Δt by -0.54±0.11 nS/min (n=4, p<0.05). After uncoupling cells were treated with 50 nM AAP10, which reversed uncoupling leading to increase in Δj/Δt by +0.29±0.13 nS/min (n=4, p<0.05) and ending up in macroscopic gap junction conductance above the control level ( fig.   3B ).
AAP10 does not affect I(Na) in human cardiomyocytes
Under control conditions a maximum I(Na) of about 120 pA/pF was found at -45 mV in good correspondence with others 23 . Voltage clamp revealed that neither the maximum I(Na) current nor the current-voltage relationship were altered by 50 nM AAP10 ( fig. 3C; n=6 ). The fact that the AAP10-effect is enhanced in acidosis-uncoupled cells may involve many factors like receptor sensitivity, receptor coupling and unknown interactions between PKCα and those factor involved in pH-dependent channel closing. However, this enhancement of the AAP10-effect in uncoupled cells could mean some preference of AAP10 for uncoupled tissue, such as ischemic tissue. In accordance with this hypothesis, that Zp123 (now called rotigaptide, a peptide chemically closely related to AAP10) prevents atrial conduction slowing during metabolic stress in isolated atria from Sprague-Dawley rats 31 (and see below). From our present finding that AAP10 effects are more pronounced in uncoupled cells, one could suggest that AAP10 may exert local effects in e.g. an ischemic zone but only minor effects in the non-ischemic zone, which could be recently shown in an isolated rabbit heart model of local ischemia 32 (and see below). In continuation of our previous studies, our present data
AAP10 enhances gap junctional permeability (metabolic coupling) in rat cardiomyocytes
show that AAP10 also works in human cardiomyocytes.
Regarding the effects of AAP10 in comparison to the chemically closely related successor drug rotigaptide (formerly named ZP123) rotigaptide pre-treatment prevented from acidosisinduced conduction slowing in good accordance with our present data 33 . Moreover, prevention of ischemia-induced de-coupling by rotigaptide pre-treatment 34 or AAP10 pretreatment was described 32 . Interestingly, it was reported that rotigaptide suppressed atrial fibrillation only in the acute ischemic substrate but not in an atrial tachypacing model 35 , and not in a volume overload model 36 , although it improved conduction velocities in all these models. This was explained by the authors by differences in the contribution of gap junction dysfunction to the various models of atrial tachyarrhythmia 35 . An effect on I(Na) was not seen with rotigaptide 33 , as we also could not find such an effect in the human cardiomyocytes with AAP10. In atria submitted to metabolic stress rotigaptide treatment was also effective to revert conduction slowing 37 as was pre-treatment 31 . On the molecular level this was explained by the findings that ischemia-induced de-phosphorylation was antagonized by both rotigaptide 12 and AAP10 pre-treatment 32 .
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Accepted Manuscript investigated here. Regarding the AAP10-successor rotigaptide, it was shown that rotigaptide acts on Cx43, but not on Cx26 or Cx32 13 , which also supports the view that these antiarrhythmic peptide do not affect all connexins.
A first conclusion is that AAP10 probably will exert only minor effects on the cardiac specific conduction system, since in these structures (including sinus node, AV-node, bundle of His, bundle branches, Purkinje fibres) cells are mostly coupled by Cx40. In good accordance with this consideration, no effect on atrioventricular conduction or on the specific conduction system has been seen with AAP10, ZP123 or rotigaptide so far 4,10-11,31-32 . This might be beneficial if a sole action on working myocardium is desired.
From the our present data and the considerations above it can be concluded that AAP10 HelaCx43, HeLa Cx45 with -46.9/+55.1; -78.3/+71.9 and -25.7/+18.4, respectively and for rat cardiomyocytes -47.8/+47.7 15 , which is in good correspondence to other work [44] [45] [46] .
Regarding g min values in human cardiomyocytes these are higher than those found and published for HeLa cells. This might be due to much higher conductance levels between the human cardiomyocyte cell pairs. Although the measurement of voltage sensitivity can be contaminated by series resistance and is difficult to detect in well coupled cells, in our measurement system the series resistance is overcome by the electrical circuit provided by the switch clamp system 17 . From this data on voltage-dependent inactivation, the human gap junction currents probably may predominantly represent Cx43 currents, and to a lower extent by guest on May 1, 2016
Accepted Manuscript
Cx40 and Cx45 currents. This view would also fit to our protein and immunohistology data regarding connexin expression in the human specimen, showing Cx43 as the predominant isoform.
Limitations
In freshly isolated human cardiomyocytes metabolic coupling cannot be investigated, since a subconfluent or confluent culture is necessary to measure dye transfer over several cells.
However, it is impossible to study this effect in classical adult cardiomyocyte cultures since these cells after isolation decrease their Cx43 expression and several days after isolation in culture they change their morphology to a more embryonic type and then again increase Addition of 50nmol/l AAP10 prevented uncoupling and furthermore increased gap junction conductance (see also fig. 2 and 3 ). There was also increase in gap junction conductance by AAP10 at pH 7.4 (B, D). 
